CIK 0001867066 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Journey Medical Corp
Sign in to watch- Ticker
- DERM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471879539
- Phone
- 480-434-6670
- Business address
- 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
- 4 Grant or award Director acquired 27,472 shares (grant or award)
- 4 Open-market sale President & CEO sold 20,767 shares at $1.76 ($36,550)
- 4 Open-market sale See Remarks sold 4,072 shares at $1.76 ($7,167)
- 4 Open-market sale President & CEO sold 44,377 shares at an average $1.30 ($57,665)
- 4/A Open-market sale See Remarks sold 10,093 shares at $2.41 ($24,324)
- 4 Open-market sale Interim CFO sold 2,768 shares at $1.97 ($5,453)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 10,093 shares at $2.41 ($24,324)
- 4 Grant or award Director acquired 14,245 shares (grant or award)
- 4 Grant or award Director acquired 14,245 shares (grant or award)
- 4 Grant or award Director acquired 14,245 shares (grant or award)
- 4 Grant or award Director acquired 14,245 shares (grant or award)
- 4 Grant or award Director acquired 14,245 shares (grant or award)
- 4 Grant or award President & CEO acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
Page 4 of 5 · 88 filings